Anti-Human CD256/TNFSF13 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22087; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-Human CD256/TNFSF13 Polyclonal Antibody – a powerful tool for your biotech research needs.
This antibody is specifically designed to target CD256, also known as TNFSF13, a protein that plays a crucial role in immune response and inflammation. CD256 is a member of the tumor necrosis factor (TNF) superfamily and is involved in various signaling pathways, making it a key target for biotech research.
Our Anti-Human CD256/TNFSF13 Polyclonal Antibody is highly specific and sensitive, allowing for precise detection and quantification of CD256 in various biological samples. It is produced using state-of-the-art technology and rigorously tested to ensure the highest quality and reproducibility.
One of the main applications of this antibody is in the study of autoimmune diseases, as CD256 has been shown to be involved in the development and progression of these conditions. Additionally, it can be used in cancer research, as CD256 has been linked to tumor growth and metastasis.
Our antibody has been successfully used in various experimental settings, including Western blotting, immunohistochemistry, and flow cytometry. Its versatility and reliability make it a valuable tool for any biotech laboratory.
ProteoGenix catalogue number ARO-A22087. For research use only.
Target: Tumor necrosis factor ligand superfamily member 13, A proliferation-inducing ligand, APRIL, TNF- and APOL-related leukocyte expressed ligand 2, TALL-2, TNF-related death ligand 1, TRDL-1, CD256, TNFSF13, APRIL, TALL2, ZTNF2; Clonality: Polyclonal Antibody; Reactivity: Human; Applications: IHC, ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
